Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Coeur Mining’s Strategic Acquisition and Market Momentum

Robert Sasse by Robert Sasse
December 23, 2025
in Analysis, Commodities, Gold & Precious Metals, Market Commentary, Mergers & Acquisitions
0
Coeur Mining Stock
0
SHARES
45
VIEWS
Share on FacebookShare on Twitter

The equity of Coeur Mining is experiencing a significant uplift, driven by a confluence of strategic and market factors. Beyond near-term volatility, the primary focus for investors is the enhanced potential of the combined entity projected for 2026, fueled by the planned merger with New Gold, favorable precious metals pricing, and growing institutional conviction.

Operational Performance and Macroeconomic Tailwinds

Coeur’s recent operational results provide a solid foundation for its market strength. The company reported third-quarter revenue of $554.6 million, surpassing market expectations of $521.6 million by approximately 6%. While its earnings per share (EPS) of $0.23 came in slightly below the consensus estimate of $0.25, the company benefited directly from elevated metal prices and strong operational throughput.

The current macroeconomic environment is highly supportive. Gold prices are holding above $4,300 per ounce, with silver also demonstrating robust pricing. As an unhedged producer, Coeur Mining is positioned to capture the full benefit of these price increases, thereby expanding its operating margins. Concurrently, the company has reduced its net debt, strengthening its balance sheet ahead of the proposed merger.

The New Gold Merger: A Transformative Deal

At the heart of the investment thesis is the all-stock acquisition of New Gold, valued at approximately $7 billion. This consolidation is designed to create a leading North American precious metals producer with clearly outlined post-merger objectives:

  • Ownership & Exchange: Upon completion, Coeur shareholders are expected to own about 62% of the new company, with New Gold shareholders holding the remaining 38%. The exchange ratio is set at 0.4959 Coeur shares for each New Gold share.
  • Production & Financial Targets: The combined entity aims for an annual production rate of roughly 1.25 million gold equivalent ounces. By 2026, the company is targeting EBITDA of around $3.0 billion and free cash flow of $2.0 billion.
  • Geographic Focus: Over 80% of the revenue is projected to originate from mining operations in the United States and Canada.

A key milestone is already scheduled: a shareholder vote on the transaction is set for January 27, 2026, providing the market with a clear timeline for the deal’s progression.

Should investors sell immediately? Or is it worth buying Coeur Mining?

Institutional Confidence and Technical Positioning

Significant buying activity from major investors underscores the positive sentiment. Notably, Voya Investment Management increased its position in Coeur Mining by 246.5% during the third quarter. It now holds 608,227 shares valued at approximately $11.41 million. Such substantial accumulation by institutional players is often interpreted as a strong vote of confidence in the company’s medium-term trajectory.

This fundamental optimism is reflected in the share price performance. The stock has advanced by about 25% over the past 30 days and has surged more than 160% since the start of the year. Currently trading at €16.20, it sits well above its 200-day moving average of €10.54, confirming a sustained upward trend. While the 50-day moving average of €13.87 remains below the current price, the 14-day Relative Strength Index (RSI) of 50.0 suggests a neutral momentum, indicating the recent rally has not yet entered overbought territory.

Analyst Outlook and Forward Assessment

Market analysts are incorporating these developments into their models. Roth Capital has raised its price target for Coeur Mining from $20 to $23 per share, maintaining a “Buy” recommendation. This adjustment is based on revised, near-record forecasts for gold and silver prices, which enhance the company’s earnings potential.

Looking ahead to 2026, the narrative is constructive. Investors are monitoring a clear path of rising production, a well-defined merger plan, supportive institutional activity, and a favorable commodity backdrop. The immediate focal point is the shareholder vote scheduled for late January 2026. In the medium term, market participants will be evaluating the company’s success in achieving its stated goals of 1.25 million gold equivalent ounces in annual production, alongside the targeted $3.0 billion in EBITDA and $2.0 billion in free cash flow.

Ad

Coeur Mining Stock: Buy or Sell?! New Coeur Mining Analysis from March 25 delivers the answer:

The latest Coeur Mining figures speak for themselves: Urgent action needed for Coeur Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Coeur Mining: Buy or sell? Read more here...

Tags: Coeur Mining
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
Next Post
Yelp Stock

Yelp's Stock Faces Cautious Market Sentiment Despite Solid Earnings

Vulcan Energy Stock

Vulcan Energy Shares Gain on Improved Market Liquidity

Barrick Stock

Barrick Gold's Strategic Maneuvers Amid Favorable Market Conditions

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com